Austin, United States, Aug. 19, 2026 (GLOBE NEWSWIRE) -- The Interventional Cardiology Devices Market Size was valued at USD 23.71 Billion in 2025 and is projected to reach USD 45.27 Billion by 2035, growing at a CAGR of 6.68% during 2026–2035, according to a new report by SNS Insider. Increasing incidence of cardiovascular diseases, increasing demands for minimal invasive treatments, and innovations in coronary stents, structural heart devices, and catheter-based treatments are driving the growth of the global market.
Interventional Cardiology Devices Market is experiencing growth due to the rising incidence of cardiovascular diseases, aging populations, and growing inclination towards minimal invasiveness in treatment options. Interventional cardiology devices help conduct catheter-based procedures which could minimize the necessity for the traditional open surgical method and could facilitate quicker recovery of patients. Highly sophisticated coronary stents, angioplasty balloons, catheters, guided interventional methods, and structural heart devices are also driving demand within the market.
Download the Interventional Cardiology Devices Market Sample Report: https://www.snsinsider.com/sample-request/8393
Interventional Cardiology Devices Market Growth Supported by Minimally Invasive Procedures
There is an increase in demand for interventional cardiology devices owing to an increase in the number of patients who need interventional cardiology treatment. The increase in prevalence of coronary artery disease and peripheral arterial disease, along with an aging population and growing trend towards less invasive treatments that require less recovery time, have helped drive market growth.
Developments in drug eluting stents, structural heart devices, bio-absorbable technology, embolic protection devices, atherectomy devices, and image guided interventional techniques have contributed to expanding the horizon of interventional cardiology. Continued development of cardiac catheterization centers in emerging markets also provides new opportunities for device manufacturers.
Interventional Cardiology Devices Market Key Takeaways
- Leading Product: Coronary Stents, 35.32% share in 2025
- Leading Procedure Type: PCI, 55.76% share in 2025
- Leading Technology: Drug-Eluting, 60.52% share in 2025
- Leading End User: Hospitals & ASCs, 60.22% share in 2025
- Largest Regional Market: North America, 38.80% share in 2025
- Fastest-Growing Region: Asia Pacific, 7.07% CAGR
North America Leads the Interventional Cardiology Devices Market While Asia Pacific Records the Fastest Growth
North America dominated the Interventional Cardiology Devices Market with a 38.80% revenue share in 2025. The region is favored by existing healthcare infrastructure, heavy cardiovascular disease burden, significant acceptance of procedures like PCI and structural heart procedures, and availability of medical device manufacturers. R&D activities and reimbursement systems also favor market growth in the region.
The U.S. Interventional Cardiology Devices Market was valued at USD 6.06 Billion in 2025 and is projected to reach USD 11.33 Billion by 2035, growing at a CAGR of 6.46%. Growth is supported by the increased presence of cardiovascular disease, the demand for minimally invasive cardiovascular treatments, manufacturing experience in medical devices, and research in cardiovascular technologies.
The Europe Interventional Cardiology Devices Market was valued at USD 6.40 Billion in 2025 and is projected to reach USD 12.01 Billion by 2035, expanding at a CAGR of 6.50%. This growth is attributed to the prevalence of cardiovascular diseases, aging population, and increasing use of minimally invasive procedures such as PCI and structural heart intervention procedures. The advanced healthcare system, favorable reimbursement policies, and use of drug eluting and bio-absorbable technology devices are additional factors fueling the market growth.
Asia Pacific is projected to register the fastest CAGR of 7.07% during 2026–2035, supported by high prevalence of cardiovascular diseases, increased healthcare infrastructure and awareness about minimally invasive cardiovascular treatments. Increased presence of catheterization labs and investments in healthcare in China, India, and Japan are driving the regional market.
Interventional Cardiology Devices Market Segmentation Analysis
Coronary Stents Lead the Market by Product
Coronary Stents held the largest market share of 35.32% in 2025, supported by their widespread use in PCI procedures and growing demand for minimally invasive coronary interventions. Structural Heart Devices are projected to register the fastest CAGR of 7.41% through 2035, driven by increasing adoption of TAVR, MitraClip, and other advanced structural heart procedures.
PCI Dominates the Market by Procedure Type
PCI held the largest market share with about 55.76% in 2025 due to wide usage for the treatment of coronary artery disease and higher global volume of procedures performed. The Peripheral Vascular Intervention segment is anticipated to grow at the fastest pace with 7.33% CAGR owing to the rising incidences of peripheral artery disease, diabetes, and aging population.
Drug-Eluting Technology Holds the Largest Share
The Drug Eluting market held the largest share of almost 60.52% in 2025 due to its capability to lower the risk of restenosis. The Biodegradable market is expected to exhibit the highest CAGR of 7.75% during the forecast period due to advancements in biodegradable polymers, provisional scaffolding techniques, and temporary solutions.
Hospitals and ASCs Lead Market Demand
The Hospitals & ASCs segment accounted for about 60.22% share of the market in 2025 owing to their well-established healthcare infrastructure, availability of cardiologists, procedure volume, and integration with imaging. Additionally, this segment is likely to witness the highest growth CAGR of 6.85% during the forecast period due to an increase in outpatient heart procedures and ASCs.
Explore the Complete Interventional Cardiology Devices Market Report: https://www.snsinsider.com/reports/interventional-cardiology-devices-market-8393
Leading Market Players Listed in this Report are:
- Boston Scientific Corporation
- Medtronic plc
- Abbott Laboratories
- Edwards Lifesciences Corporation
- Terumo Corporation
- Siemens Healthineers
- Philips Healthcare
- Johnson & Johnson
- Cook Medical
- Becton Dickinson
- Cardinal Health
- MicroPort Scientific Corporation
- LivaNova PLC
- Merit Medical Systems, Inc.
- Sorin Group
- ABIOMED, Inc.
- Terumo Interventional Systems
- Claret Medical, Inc.
- Neovasc Inc.
Recent Developments:
- 2025: Boston Scientific expanded its interventional cardiology portfolio with the launch of the SYNERGY XD drug-eluting stent in Europe and expanded structural heart device activities in Asia Pacific.
- 2025: Medtronic introduced the IN.PACT Admiral drug-coated balloon in the U.S. and expanded robotic-assisted PCI systems across Europe and Latin America.
Interventional Cardiology Devices Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 23.71 billion |
| Market Size by 2035 | USD 45.27 billion |
| CAGR | CAGR of 6.68% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Key Segments | • By Product (Coronary Stents, Structural Heart Devices, Angioplasty Balloons, Catheters, Embolic Protection Devices, PTCA Balloon Catheters, Others) • By Procedure Type (Percutaneous Coronary Intervention (PCI), Peripheral Vascular Intervention, Structural Heart Procedures) • By Technology (Drug-Eluting, Biodegradable, Advanced Imaging) • By End User (Hospitals & ASCs, Catheterization Labs & Others) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Buy the Interventional Cardiology Devices Market Report with Competitive Analysis and 2035 Forecast: https://www.snsinsider.com/checkout/8393
Exclusive Sections of the Report (The USPs):
- PROCEDURE VOLUME TRENDS – helps you assess the growth and changing demand for PCI, angioplasty, stenting, and other interventional cardiology procedures across global and regional markets.
- PATIENT DEMOGRAPHICS & UTILIZATION – helps you understand age-wise, gender-wise, urban-rural, and insurance-based utilization patterns influencing demand for interventional cardiology devices.
- CARDIAC CENTER INFRASTRUCTURE TRENDS – helps you evaluate the expansion of cath labs and cardiac facilities, including regional capacity, new facility launches, and staffing requirements.
- REIMBURSEMENT & PAYER MIX ANALYSIS – helps you assess the influence of Medicare, Medicaid, private insurance, and out-of-pocket payments on procedure volumes and device adoption.
- DEVICE COST SAVINGS ANALYSIS – helps you quantify the economic benefits of minimally invasive devices compared with traditional surgery and identify cost-efficiency opportunities.
- DEVICE PRICING TRENDS – helps you compare pricing patterns for major interventional cardiology devices, including stents, balloons, guidewires, and embolic protection systems.
Related Market Reports
Coronary Stent Market Size 2026
Drug Eluting Stent Market Growth 2026
Angioplasty Balloon Market Trends 2026
Transcatheter Heart Valve Replacement Market Outlook 2026
Transcatheter Mitral Valve Market Size 2026
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
